Karuna Therapeutics Q2 EPS $(1.17) Down From $(0.65) YoY

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(1.17) per share. This is a 80 percent decrease over losses of $(0.65) per share from the same period last year.

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(1.17) per share. This is a 80 percent decrease over losses of $(0.65) per share from the same period last year.

Total
0
Shares
Related Posts